ARTICLE 1 DEFINITIONSStandstill Agreement • January 7th, 2002 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone)
by and amongIrrevocable Trust Agreement • January 7th, 2002 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone) • Delaware
SHAREHOLDER AGREEMENT (Voting)Shareholder Agreement (Voting) • May 8th, 2006 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone) • California
This SHAREHOLDER AGREEMENT (this “Agreement”), dated as of April 26, 2006, is by and between Siemens Medical Solutions USA, Inc., a Delaware corporation (the “Purchaser”) and each of the shareholder(s) set forth in the signature pages hereto (each, a “Shareholder” and collectively, the “Shareholders”).
WARRANT TO PURCHASE COMMON STOCK OF SEQUENOM, INC.Securities Purchase Agreement • June 12th, 2006 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone) • New York
THIS WARRANT IS MADE AND DELIVERED PURSUANT TO A CERTAIN AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT, DATED AS OF MARCH 30, 2006, AND SUBJECT TO THE TERMS AND CONDITIONS THEREOF.
AMENDMENT NO. 1 TO DEPOSIT AGREEMENTDeposit Agreement • May 4th, 2007 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone)
AMENDMENT NO. 1 dated as of May [●], 2007 (the "Amendment") to the Deposit Agreement dated as of March 1, 2001 (the "Deposit Agreement"), among Siemens Aktiengesellschaft (the "Company"), incorporated under the laws of The Federal Republic of Germany, JPMorgan Chase Bank, N.A., as depositary (the "Depositary"), and all Holders and Beneficial Owners from time to time of American Depositary Receipts ("ADRs") issued thereunder.
Exhibit A Joint Filing AgreementJoint Filing Agreement • May 21st, 2008 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone)
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other of a statement on Schedule 13D (including all amendments thereto) (the “Statement”) with respect to the common stock, par value $0.001, of Sequenom, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such Statement. In evidence whereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of this 21st day of May, 2008.
JOINT FILING AGREEMENTJoint Filing Agreement • April 29th, 2005 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone)
The undersigned hereby agree that the Statement on Schedule 13D, dated March 28, 2005, with respect to the shares of common stock, par value $0.01 per share, and the associated preferred stock purchase rights CTI Molecular Imaging, Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to the Schedule 13D and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • March 28th, 2005 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone)
The undersigned hereby agree that the Statement on Schedule 13D, dated March 28, 2005, with respect to the shares of common stock, par value $0.01 per share, and the associated preferred stock purchase rights CTI Molecular Imaging, Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to the Schedule 13D and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
Exhibit A Joint Filing AgreementJoint Filing Agreement • June 12th, 2006 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone)
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other of a statement on Schedule 13D (including all amendments thereto) (the “Statement”) with respect to the common stock, par value $0.001, of Sequenom, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such Statement. In evidence whereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of this 12th day of June, 2006.
JOINT FILING AGREEMENTJoint Filing Agreement • May 8th, 2006 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone)
Pursuant to Rule 13d-1(k)(1) of the Securities and Exchange Commission under the Securities and Exchange Act of 1934, as amended, each of the undersigned agrees that the statement on Schedule 13D filed herewith shall be filed on behalf of each of the undersigned.
CONFIDENTIALITY AGREEMENTConfidentiality Agreement • August 8th, 2007 • Siemens Aktiengesellschaft • Telephone communications (no radiotelephone) • Delaware
This CONFIDENTIALITY AGREEMENT (this “Agreement”) is dated as of May 22, 2007, and is by and between Dade Behring Holdings, Inc. (the “Company”) and Siemens Medical Solutions U.S.A., Inc. (“Recipient”). Recipient and the Company are sometimes collectively referred to herein as the “Parties” and individually as a “Party.” Certain capitalized terms used herein have the meanings set forth in Section 9.
